Cite
APA Citation
Wright, K. D., Zimmerman, M. A., Fine, E., Aspri, T., Kieran, M. W., & Chi, S. (n.d.). lGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY. Neuro-oncology, 20(2), i110. http://access.bl.uk/ark:/81055/vdc_100095510279.0x000013